Skip to main content

Renal Insufficiency and Clinical Outcomes in Acute Ischemic Stroke With Large Infarct: A Prospective Cohort Analysis

In brief

Thrombectomy linked to better recovery after large strokes, despite more bleeding

In a prospective cohort of 745 patients with large ischemic strokes, endovascular treatment was associated with better 90-day function in patients with and without renal insufficiency. It was also associated with more symptomatic brain hemorrhage, while mortality did not differ significantly. The analysis found no evidence that kidney function changed treatment effects, but it cannot establish cause and effect.

Journal
Journal of the American Heart Association (Q1)
Published
12 November 2026
Study design
Prospective / inception cohort
Evidence level
Level 2, Moderate (CEBM 2b)
Authors
Jinfu Ma, Lilan Wang, Zhouzhou Peng, Min Zhao, Changwei Guo, Jiaxing Song, et al.
PMID
43018048
DOI
10.1161/JAHA.126.050498

Why clinicians should know about it

  • Picked for Neurology (clinical) (paper of the day, 16 November 2026): Endovascular thrombectomy outcomes in large-infarct ischemic stroke

Abstract

BACKGROUND: This study aimed to investigate whether renal insufficiency (RI) modifies the effectiveness and safety of endovascular treatment (EVT) in patients with acute ischemic stroke and large infarct in a real-world setting. METHODS: This study was a post hoc analysis of a prospective multicenter cohort study. RI was defined as an estimated glomerular filtration rate <90 mL/min per 1.73 m2 on admission. Patients were treated with EVT plus standard medical treatment or standard medical treatment alone and were stratified by RI status. The primary effectiveness outcome was favorable outcome (modified Rankin scale 0-3) at 90 days. Safety outcomes included symptomatic intracranial hemorrhage and 90-day mortality. RESULTS: Among 745 patients with acute ischemic stroke and large infarct, 343 (46.0%) had RI and 490 (65.8%) underwent EVT. Compared with standard medical treatment, EVT was associated with improved functional outcomes (modified Rankin scale 0-3) in both the RI (adjusted odds ratio [OR] 2.55 [95% CI, 1.15-5.68], P=0.022) and the non-RI group (adjusted OR 2.65 [95% CI, 1.49-4.73], P=0.001). EVT was also associated with higher risks of symptomatic intracranial hemorrhage in both groups (P=0.002 and 0.007, respectively), whereas no significant difference in mortality was observed. Results were consistent in the inverse probability-weighted analyses. No statistically significant interaction was observed between RI status and treatment effect for effectiveness or safety outcomes. CONCLUSIONS: In patients with acute ischemic stroke and large infarct, EVT was associated with improved functional outcomes but a higher risk of hemorrhagic complications. We did not find statistically significant evidence of interaction between EVT and RI status for 90-day outcomes.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.